Proliferating status of peripheral blood progenitor cells from patients with BCR-ABL positive chronic myelogenous leukemia.

被引：0
|
作者：
Krämer, A [1 ]
Bergmann, J [1 ]
Willer, A [1 ]
Reiter, A [1 ]
Hochhaus, A [1 ]
Hehlmann, R [1 ]
机构：
[1] Univ Heidelberg, Klinikum Mannheim, Med Klin 3, Mannheim, Germany
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2383
引用
收藏
页码：533A / 533A
页数：1
相关论文
共 50 条
  • [41] Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term culture
    Schultheis, B
    Heissig, B
    Pasternak, G
    Hörner, S
    Hehlmann, R
    FOLIA BIOLOGICA, 2000, 46 (06) : 251 - 255
  • [42] Transplantation of autologous peripheral blood progenitor cells for patients with secondary acute myelogenous leukemia.
    Schiller, G
    Lill, M
    Lee, M
    Sawyers, C
    Paquette, R
    Territo, M
    BLOOD, 1997, 90 (10) : 372 - 372
  • [43] DETECTION BY ENZYMATIC AMPLIFICATION OF BCR-ABL MESSENGER-RNA IN PERIPHERAL-BLOOD AND BONE-MARROW CELLS OF PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA
    LANGE, W
    SNYDER, DS
    CASTRO, R
    ROSSI, JJ
    BLUME, KG
    BLOOD, 1989, 73 (06) : 1735 - 1741
  • [44] Targeting the genomic DNA of the BCR-ABL gene as a new molecular treatment strategy for chronic myelogenous leukemia.
    Topaly, J
    Radujkovic, A
    Braun, K
    Debus, J
    Zeller, WJ
    Ho, AD
    Fruehauf, S
    BLOOD, 2003, 102 (11) : 651A - 651A
  • [45] Induction of BCR-ABL mutations for acquired resistance in chronic myelogenous leukemia cells by imatinib
    Yuan, Hongfeng
    Gao, Chunggang
    Bhatia, Ravi
    Chen, WenYong
    CANCER RESEARCH, 2009, 69
  • [46] Quantification of BCR-ABL transcripts by competitive polymerase chain reaction in leukapheresis-collected blood progenitor cells from early diagnosed patients with chronic myeloid leukemia.
    Corsetti, MT
    Frassoni, F
    Podesta, M
    Lerma, E
    Dejana, A
    Celesti, L
    Parodi, C
    Manca, F
    Carella, AM
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 495 - 495
  • [47] Inhibition of BCR-ABL signaling in imatinib sensitive and resistant chronic myelogenous leukemia and progenitor cells through small molecule-mediated BCR-ABL ubiquitination and aggresomal deposition
    Donato, Nicholas
    Sun, Hanshi
    Kapuria, Vaibhav
    Peterson, Luke
    Peng, Zhenghong
    Maxwell, David
    Bornmann, William
    Talpaz, Moshe
    CANCER RESEARCH, 2009, 69
  • [48] Follow-up of childhood chronic myelogenous leukemia with monitoring the BCR-ABL fusion gene expression in peripheral blood
    Horvath, Adrienne
    Baghiu, Maria Despina
    Pap, Zsuzsanna
    Banescu, Claudia
    Marginean, Cristina Oana
    Pavai, Z.
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2011, 52 (03): : 907 - 913
  • [49] Inadequate BCR-ABL monitoring in imatinib-treated patients with chronic myelogenous leukemia
    Stanek, E.
    Aubert, R. E.
    Sanders, C.
    Frueh, F. W.
    Yao, J.
    Epstein, R. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [50] BCR-ABL - AN ANTI-APOPTOSIS GENE IN CHRONIC MYELOGENOUS LEUKEMIA
    COTTER, TG
    LEUKEMIA & LYMPHOMA, 1995, 18 (3-4) : 231 - 236
12345